HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 HOTSPOT THERAPEUTICS, INC., Case No. 22-cv-04109-TSH

Plaintiff, ORDER RE:

PLAINTIFF/COUNTERCLAIM

v. DEFENDANT’S MOTION TO STAY

DISCOVERY (PUBLIC REDACTED

NURIX THERAPEUTICS, INC., VERSION OF ECF NO. 101) Defendant. Re: Dkt. Nos. 72, 73, 80, 88, 89, 90,

12 I. INTRODUCTION Pending before the Court are Plaintiff/Counterclaim Defendant HotSpot Therapeutics, Inc.’s (“HotSpot’s”) Motion to stay discovery until Nurix Therapeutics, Inc. (“Nurix”) satisfies the pre-discovery requirement to identify the trade secrets it alleges to be misappropriated by HotSpot (ECF No. 73) and related Administrative Motions to Seal (ECF Nos. 72, 80, 90). On March 16, 2023, Nurix filed Opposition. ECF No. 81. On March 23, 2023, HotSpot filed a Reply. ECF No. 91. Additionally pending is a Motion to strike portions of Nurix’s Opposition (ECF No. 89) and related Administrative Motions to Seal (ECF Nos.…